Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Biocidal product factsheet - Last updated: 16/04/2024

Biocidal Product details

Trade name:

-

impralit ACA protect

Product-type:

PT08

Active Substance details

IUPAC name:

1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole

EC number:

262-104-4

CAS number:

60207-90-1

BAS number:

48

The Active Substance is a candidate for substitution

Substance name:

IUPAC name:

Copper(II) carbonate-copper(II) hydroxide (1:1)

EC number:

235-113-6

CAS number:

12069-69-1

BAS number:

6

Substance name:

IUPAC name:

1-(4-chlorophenyl)-4,4- dimethyl-3-(1,2,4-triazol- 1-ylmethyl)pentan-3-ol

EC number:

403-640-2

CAS number:

107534-96-3

BAS number:

51

The Active Substance is a candidate for substitution

Authorised
map
Authorisation information

Authorisation type:

National authorisation

Legal act:

Assessment reports:

12 authorisations in the product cluster
Authorisation number SPC Decisions

impralit ACA protect

PT08

Czech Republic

Rütgers Organics GmbH CZ-0019603-0001 CZ-0019603-0000 09/06/2017 09/06/2024

Family SPC  (en)

Member SPC  (en)

55514_2020_podminky-povoleni_PUBLIC.pdf (cs)

podminky-povoleni_PUBLIC-impralit.pdf (cs)

Authorised

impralit ACA protect

PT08

Belgium

Rütgers Organics GmbH BE-0020161-0001 BE2019-0024-00-00 09/06/2017 09/06/2024

Family SPC  (fr)

Member SPC  (fr)

BE2019-0024-01-01_ACT.pdf (fr)

BE2019-0024-01-02_ACT.pdf (fr)

BE2019-0024-00-00_ACT.pdf (fr)

BE2019-0024-01-00_ACT.pdf (fr)

Authorised

impralit ACA protect

PT08

Finland

Rütgers Organics GmbH FI-0020232-0001 FI-2019-0026 (family) 11/12/2019 09/06/2024

Family SPC  (fi)

Member SPC  (fi)

impralit_ACA_protect_family_authorisation_11122019.pdf (fi)

impralit_ACA_protect_family_NA-AAT_20062022.pdf (fi)

impralit_ACA_protect_family_NAAAT_31052023.pdf (fi)

Authorised

impralit ACA protect

PT08

Germany

Rütgers Organics GmbH DE-0020307-0001 DE-0020307-00-0000-08 09/06/2017 09/06/2024

Family SPC  (de)

Member SPC  (de)

Authorised

-

PT08

Greece

Rütgers Organics GmbH GR-0029460-0001 ΤΠ8-0150-ΟΠ 26/09/2022 09/06/2024

Family SPC  (el)

Member SPC  (el)

PT8-0150-PF (impralit ACA Protect family_MRS).pdf (el)

TP8-0150-OP (impralit ACA Protect family_MRS) VAR APRIL 2024.pdf (el)

PT8-0150 Family_EXT._JUNE_2023.pdf (el)

Authorised

impralit ACA protect

PT08

Ireland

Rütgers Organics GmbH IE-0024337-0001 IE/BPA 70770 09/06/2017 09/06/2024

Family SPC  (en)

Member SPC  (en)

IE-BPA 70770 Authorisation Certificate Ver 1.2.pdf (en)

Authorised

impralit ACA protect

PT08

Netherlands

Rütgers Organics GmbH NL-0030870-0001 NL-0030870-0000 06/09/2023 09/06/2024

Family SPC  (nl)

Member SPC  (nl)

20230906_NL-0030870-0000 Authorisation.pdf (nl)

Authorised

impralit ACA protect

PT08

Norway

Rütgers Organics GmbH NO-0022175-0001 NO-2020-0190 09/06/2017 09/06/2024

Family SPC  (no)

Member SPC  (no)

NO-0022175-0000_authorisation.pdf (en)

NO-0022175-0000_extension of expiry date 2023.pdf (en)

NO-0022175-0000_extension of expiry date_2022.pdf (en)

Authorised

impralit ACA protect

PT08

Portugal

Rütgers Organics GmbH PT-0030861-0001 PT/DGAV ARMPB08 -11/2023; PT/DGAV ARMPB08 -12/2023 18/05/2023 09/06/2024

Family SPC  (pt)

Member SPC  (pt)

P.475 - impralit ACA protect family - T�tulo.pdf (pt)

Authorised

-

PT08

Spain

Rütgers Organics GmbH ES-0031057-0001 ES/MRF(NA)-2023-08-00900 27/10/2023 09/06/2024

Family SPC  (es)

Member SPC  (es)

R4BP3-ES-0031057-0000-Authorisation.pdf (es)

Authorised

Impralit ACA protect

PT08

Sweden

Rütgers Organics GmbH SE-0020304-0001 5675 16/04/2021 09/06/2024

Family SPC  (sv)

Member SPC  (sv)

5675_Beslut_2023-05-12.pdf (sv)

5675_Beslut_2022-05-18.pdf (en)

5675_Beslut_2021-04-16.pdf (sv)

Authorised

impralit ACA protect

PT08

Switzerland

Rütgers Organics GmbH CH-0026677-0001 CH-2021-0013 08/07/2021 09/06/2024

Family SPC  (de)

Member SPC  (de)

Authorised
Reference authorisation
Trade name: impralit ACA protect
Authorisation number: CZ-0019603-0001| Market area: Czech Republic

4 assessment records available

Amendment of national authorisation

Evaluating authority:

Czech Republic

Conclusion date:

30/05/2023

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2024

SPC

Family SPC  (en)

Member SPC  (en)

Amendment of national authorisation

Evaluating authority:

Czech Republic

Conclusion date:

12/05/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Czech Republic

Conclusion date:

28/12/2020

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2022

SPC

SPC not available

Application of national authorisation

Evaluating authority:

Czech Republic

Conclusion date:

09/10/2018

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2022

SPC

SPC not available

Mutual recognition
Trade name: impralit ACA protect
Authorisation number: BE-0020161-0001| Market area: Belgium

6 assessment records available

Amendment of national authorisation

Evaluating authority:

Belgium

Conclusion date:

12/03/2024

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2024

SPC

Family SPC  (fr)

Member SPC  (fr)

Amendment of national authorisation

Evaluating authority:

Belgium

Conclusion date:

30/06/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Belgium

Conclusion date:

23/06/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Belgium

Conclusion date:

23/06/2022

Validity of authorisation

Start date:

09/06/2017

End date:

06/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Belgium

Conclusion date:

04/06/2019

Validity of authorisation

Start date:

30/05/2019

End date:

09/06/2022

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Belgium

Conclusion date:

28/05/2019

Validity of authorisation

Start date:

28/05/2019

End date:

09/06/2022

SPC

SPC not available

Trade name: impralit ACA protect
Authorisation number: FI-0020232-0001| Market area: Finland

3 assessment records available

Amendment of national authorisation

Evaluating authority:

Finland

Conclusion date:

31/05/2023

Validity of authorisation

Start date:

11/12/2019

End date:

09/06/2024

SPC

Family SPC  (fi)

Member SPC  (fi)

Amendment of national authorisation

Evaluating authority:

Finland

Conclusion date:

20/06/2022

Validity of authorisation

Start date:

11/12/2019

End date:

09/06/2023

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Finland

Conclusion date:

11/12/2019

Validity of authorisation

Start date:

11/12/2019

End date:

09/06/2022

SPC

SPC not available

Trade name: impralit ACA protect
Authorisation number: DE-0020307-0001| Market area: Germany

4 assessment records available

Amendment of national authorisation

Evaluating authority:

Germany

Conclusion date:

01/06/2023

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2024

SPC

Family SPC  (de)

Member SPC  (de)

Amendment of national authorisation

Evaluating authority:

Germany

Conclusion date:

30/05/2022

Validity of authorisation

Start date:

10/08/2020

End date:

09/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Germany

Conclusion date:

27/08/2020

Validity of authorisation

Start date:

10/08/2020

End date:

09/06/2022

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Germany

Conclusion date:

10/08/2020

Validity of authorisation

Start date:

10/08/2020

End date:

09/06/2022

SPC

SPC not available

Trade name: -
Authorisation number: GR-0029460-0001| Market area: Greece

3 assessment records available

Amendment of national authorisation

Evaluating authority:

Greece

Conclusion date:

12/04/2024

Validity of authorisation

Start date:

26/09/2022

End date:

09/06/2024

SPC

Family SPC  (el)

Member SPC  (el)

Amendment of national authorisation

Evaluating authority:

Greece

Conclusion date:

14/06/2023

Validity of authorisation

Start date:

26/09/2022

End date:

09/06/2024

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Greece

Conclusion date:

28/09/2022

Validity of authorisation

Start date:

26/09/2022

End date:

09/06/2023

SPC

SPC not available

Trade name: impralit ACA protect
Authorisation number: IE-0024337-0001| Market area: Ireland

4 assessment records available

Amendment of national authorisation

Evaluating authority:

Ireland

Conclusion date:

02/06/2023

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2024

SPC

Family SPC  (en)

Member SPC  (en)

Amendment of national authorisation

Evaluating authority:

Ireland

Conclusion date:

21/10/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Ireland

Conclusion date:

08/07/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Ireland

Conclusion date:

26/05/2021

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2022

SPC

SPC not available

Trade name: impralit ACA protect
Authorisation number: NL-0030870-0001| Market area: Netherlands

1 assessment record available

Mutual recognition in sequence

Evaluating authority:

Netherlands

Conclusion date:

30/08/2023

Validity of authorisation

Start date:

06/09/2023

End date:

09/06/2024

SPC

Family SPC  (nl)

Member SPC  (nl)

Trade name: impralit ACA protect
Authorisation number: NO-0022175-0001| Market area: Norway

3 assessment records available

Amendment of national authorisation

Evaluating authority:

Norway

Conclusion date:

31/05/2023

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2024

SPC

Family SPC  (no)

Member SPC  (no)

Amendment of national authorisation

Evaluating authority:

Norway

Conclusion date:

23/06/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Norway

Conclusion date:

17/08/2020

Validity of authorisation

Start date:

17/08/2020

End date:

09/06/2022

SPC

SPC not available

Trade name: impralit ACA protect
Authorisation number: PT-0030861-0001| Market area: Portugal

2 assessment records available

Amendment of national authorisation

Evaluating authority:

Portugal

Conclusion date:

30/05/2023

Validity of authorisation

Start date:

18/05/2023

End date:

09/06/2024

SPC

Family SPC  (pt)

Member SPC  (pt)

Mutual recognition in sequence

Evaluating authority:

Portugal

Conclusion date:

19/05/2023

Validity of authorisation

Start date:

18/05/2023

End date:

09/06/2023

SPC

SPC not available

Trade name: -
Authorisation number: ES-0031057-0001| Market area: Spain

1 assessment record available

Mutual recognition in sequence

Evaluating authority:

Spain

Conclusion date:

02/11/2023

Validity of authorisation

Start date:

27/10/2023

End date:

09/06/2024

SPC

Family SPC  (es)

Member SPC  (es)

Trade name: Impralit ACA protect
Authorisation number: SE-0020304-0001| Market area: Sweden

3 assessment records available

Amendment of national authorisation

Evaluating authority:

Sweden

Conclusion date:

12/05/2023

Validity of authorisation

Start date:

16/04/2021

End date:

09/06/2024

SPC

Family SPC  (sv)

Member SPC  (sv)

Amendment of national authorisation

Evaluating authority:

Sweden

Conclusion date:

18/05/2022

Validity of authorisation

Start date:

16/04/2021

End date:

09/06/2023

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Sweden

Conclusion date:

16/04/2021

Validity of authorisation

Start date:

16/04/2021

End date:

09/06/2022

SPC

SPC not available

Trade name: impralit ACA protect
Authorisation number: CH-0026677-0001| Market area: Switzerland

4 assessment records available

Amendment of national authorisation

Evaluating authority:

Switzerland

Conclusion date:

30/05/2023

Validity of authorisation

Start date:

08/07/2021

End date:

09/06/2024

SPC

Family SPC  (de)

Member SPC  (de)

Amendment of national authorisation

Evaluating authority:

Switzerland

Conclusion date:

23/06/2022

Validity of authorisation

Start date:

09/06/2017

End date:

09/06/2023

SPC

SPC not available

Amendment of national authorisation

Evaluating authority:

Switzerland

Conclusion date:

08/07/2021

Validity of authorisation

Start date:

08/07/2021

End date:

09/06/2022

SPC

SPC not available

Mutual recognition in sequence

Evaluating authority:

Switzerland

Conclusion date:

08/07/2021

Validity of authorisation

Start date:

08/07/2021

End date:

09/06/2022

SPC

SPC not available